| Inventor | Institute |
|---|---|
| Bart Vanhaesebroeck | Ludwig Institute for Cancer Research ; The University of Edinburgh |
| SKU: | 158393 |
|---|---|
| Genetic background: | Mice in which exons 21 and 22 from PIK3CB/p110beta are constitutively deleted by crossing to a Cre-deleter strain – backcrossed onto B6 background. |
| Production details: | Mice in which exons 21 and 22 from PIK3CB/p110beta are constitutively deleted by crossing to a Cre-deleter strain – backcrossed onto B6 background. |
| Additional notes: | Homozygous p110bD21-22/D21-22 mice can be obtained. Heterozygous mice show reduced phenotypes of homozygous. |
| Cat. #: | 158393 |
|---|---|
| Research Fields: | Cancer |
| Target: | PIK3CB |
| Model: | Knock-Out |
| Phenotype: | Homozygous p110bD21-22/D21-22 mice can be obtained. Heterozygous mice show reduced phenotypes of homozygous. |
| Shipping conditions: | Embryo/Spermatoza- Dry Ice |
|---|
| References: |
Kulkarni et al. 2011. Sci Signal. 4(168):ra23. PMID: 21487106. Guillermet-Guibert et al. 2008. Proc Natl Acad Sci U S A. 105(24):8292-7. PMID: 18544649. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.